News Release

<< Back

Ra Pharmaceuticals to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 28, 2019-- Ra Pharmaceuticals, Inc. (Nasdaq: RARX) today announced that senior management will present at the following upcoming investor conferences:

  • The Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019, at 2:30 p.m. E.T.
  • The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19, 2019, at 10:20 a.m. E.T. The conference will be held at the Lotte New York Palace in New York, NY.
  • The BMO 2019 Prescription for Success Healthcare Conference onTuesday, June 25, 2019, at 8:00 a.m. E.T. The conference will be held at the Mandarin Oriental New York in New York, NY.

The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of each presentation will be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Source: Ra Pharmaceuticals, Inc.

Investors:
Ra Pharmaceuticals
Natalie Wildenradt, 617-674-9874
nwildenradt@rapharma.com

Media:
Argot Partners
David Rosen, 212-600-1902
david.rosen@argotpartners.com